NovaBay Pharmaceuticals to rebrand as Stablecoin Development Corporation
Source: SeekingAlpha
2026-03-23 09:39:37 ET
More on NovaBay
- NovaBay: 'Hold' Rating As New M&A Direction Could Evolve But With Risks
- NovaBay plunges on sales agreement for $100M stock
- Financial information for NovaBay
Read the full article on Seeking Alpha
For further details see:
NovaBay Pharmaceuticals to rebrand as Stablecoin Development Corporation
NovaBay Pharmaceuticals Inc.
NASDAQ: NBY
NBY Trading
-5.52% G/L:
$1.37 Last:
212,233 Volume:
$1.44 Open:
NBY Latest News
October 20, 2025 07:07:28 pm
NovaBay Pharmaceuticals, Inc. Regains Compliance with NYSE American Continued Listing Standards
September 02, 2025 03:40:57 pm
Cybersecurity Surges, Biotech Booms & SaaS Shifts- 7 Hot Stocks Lighting Up into the Close
August 27, 2025 10:17:07 am
Morning Biotech Buzz: LIXTE Lights the Way, NovaBay Pays Out, and Azitra Breaks Ground
NBY Stock Data
$98,131,033
71,865,908
N/A
10
N/A
Biotechnology & Life Sciences
Healthcare
US
Emeryville
